Na Young Yeo

Na Young Yeo

Auto-generated profile, based on publicly available information

Na Young Yeo

Department of Medical Bigdata Convergence, Kangwon National University, Chuncheon, Korea

Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2024 in Journal of Korean Medical Science
Verified
Journal Article
Open access
PDF file
SPSang Won Park
Sang Won Park
NYNa Young Yeo
Na Young Yeo
SKSeong Uk Kang
Seong Uk Kang
THTaejun Ha
Taejun Ha
TKTae-Hoon Kim
Tae-Hoon Kim
OIOn behalf of the Korean Sepsis Alliance (KSA) Investigators
On behalf of the Korean Sepsis Alliance (KSA) Investigators
Park SW, et al. J Korean Med Sci. 2024 Jan;39:e53. https://doi.org/10.3346/jkms.2024.39.e53

1 January 2024 in Journal of Clinical Neurology
Verified
Journal Article
Open access
PDF file
CPChaeyoon Park
Chaeyoon Park
GJGihun Joo
Gihun Joo
MRMinji Roh
Minji Roh
SSSeunghun Shin
Seunghun Shin
SYSujin Yum
Sujin Yum
AIAlzheimer’s Disease Neuroimaging Initiative
Alzheimer’s Disease Neuroimaging Initiative
Park C, et al. J Clin Neurol. 2024 Aug;20:e60. https://doi.org/10.3988/jcn.2023.0289

30 April 2024 in Healthcare Informatics Research
Verified
Journal Article
Open access
PDF file
THTaejun Ha
Taejun Ha
SKSeong Uk Kang
Seong Uk Kang
NYNa Young Yeo
Na Young Yeo
TKTae-Hoon Kim
Tae-Hoon Kim
WKWoo-Jin Kim
Woo-Jin Kim
SPSang Won Park
Sang Won Park
Objectives: In the Fourth Industrial Revolution, there is a focus on managing diverse medical data to improve healthcare and prevent disease. The challenges include tracking detailed medical records across multiple institutions and the necessity of linking domestic public medical entities for efficient data sharing. This study explores MyHealthWay, a Korean healthcare platform designed to facilitate the integration and transfer of medical data from various sources, examining its development, importance, and legal implications.Methods: To evaluate the management status and utilization of MyHealthWay, we analyzed data types, security, legal issues, domestic versus international issues, and infrastructure. Additionally, we discussed challenges such as resource and infrastructure constraints, regulatory hurdles, and future considerations for data management.Results: The secure sharing of medical information via MyHealthWay can reduce the distance between patients and healthcare facilities, fostering personalized care and self-management of health. However, this approach faces legal challenges, particularly relating to data standardization and access to personal health information. Legal challenges in data standardization and access, particularly for secondary uses such as research, necessitate improved regulations. There is a crucial need for detailed governmental guidelines and clear data ownership standards at institutional levels.Conclusions: This report highlights the role of Korea's MyHealthWay, which was launched in 2023, in transforming healthcare through systematic data integration. Challenges include data privacy and legal complexities, and there is a need for data standardization and individual empowerment in health data management within a systematic medical big data framework.

9 February 2025 in Journal of Alzheimer’s Disease
Verified
Journal Article
Closed access
JJJae-Won Jang
Jae-Won Jang
SLSeung-Hwan Lee
Seung-Hwan Lee
TKTaesu Kim
Taesu Kim
ELEunju Lee
Eunju Lee
SPSang Won Park
Sang Won Park
YKYoung-Ju Kim
Young-Ju Kim
Background: Hearing loss is a potentially modifiable risk factor implicated in dementia, with recent research suggesting an association between age-related hearing degradation and dementia. Objective: This study aims to elucidate the relationship between hearing decline and dementia risk. Methods: We analyzed data from 511,953 subjects from the Korean National Health Insurance Service-Senior Cohort (2002–2008). After excluding those diagnosed with dementia in 2002, 511,935 subjects were included. Subjects with hearing loss between 2002 and 2008 were selected and matched with a control group without hearing impairment based on age and gender. Statistical analyses, including Pearson's chi-squared test and the Cox proportional hazards model, were conducted, controlling for confounding variables such as household income and residential area. Subgroup analysis was also performed for Alzheimer's disease and vascular dementia. Results: Subjects with hearing loss had a 1.245 times higher risk of all-cause dementia compared to those without hearing loss (adjusted hazard ratio over 3 years, 95% CI = 1.201–1.290), adjusting for gender, age, residence, and income. The adjusted hazard ratios for Alzheimer's disease over 3, 5, 7, and 10 years from the index date were 1.259 (95% CI = 1.211–1.308), 1.258 (95% CI = 1.208–1.310), 1.269 (95% CI = 1.215–1.325), and 1.235 (95% CI = 1.170–1.304), respectively. No significant association was found for vascular dementia, except for 3 years. Conclusions: Hearing loss consistently increased the risk of all-cause dementia and Alzheimer's disease across timespans, suggesting a complex link between hearing loss and neurodegenerative diseases. These findings highlight the importance of early intervention and cognitive monitoring for individuals with hearing loss.

5 October 2025 in International Journal of Medical Informatics
Verified
Journal Article
Open access
SPSang Won Park
Sang Won Park
NYNa Young Yeo
Na Young Yeo
TKTae-Hoon Kim
Tae-Hoon Kim
MLMyoung-nam Lim
Myoung-nam Lim
IYInhyeok Yim
Inhyeok Yim
WKWoo-Jin Kim
Woo-Jin Kim
Colorectal cancer (CRC) prognosis varies significantly, yet conventional statistical models struggle to capture the complex, non-linear interactions among clinical variables. Furthermore, most predictive models are based on Western populations, limiting their applicability to Korean patients. This study aimed to develop an explainable AI (XAI) model for CRC mortality prediction using a nationwide Korean cohort to provide clinically actionable insights. We conducted a retrospective cohort study using the Korean Cancer Public Library Database. A total of 9,069 patients with CRC were analyzed for all-cause mortality (1,878 deaths) and 8,589 patients for CRC-specific mortality (1,398 deaths). Four ML algorithms-support vector machine, random forest, XGBoost, and LightGBM-were constructed. We employed explainable AI techniques, including SHapley Additive exPlanations (SHAP), to quantify the contribution of each predictor and ensure model interpretability. All models showed good discrimination (AUC: 0.82-0.94). LightGBM was presented as the best-optimized model with an AUC of 0.824 [95% CI 0.80-0.85] in all-cause mortality. For CRC-specific mortality, LGB again yielded the AUC of 0.867 [95% CI 0.84-0.89]. SHAP revealed tumor stage and carcinoembryonic antigen as top mortality predictors across ages. Metabolic markers (e.g., hypertension, cholesterol) and liver enzymes were more predictive in younger patients. We developed the first interpretable machine learning model that accurately predicts CRC survival in a nationwide Korean cohort. Age-specific risk factors identified by SHAP not only support personalized care but also advance the application of precision oncology in Asian settings.